Globe Life Inc. $GL Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. lowered its holdings in Globe Life Inc. (NYSE:GL) by 2.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,004,536 shares of the company’s stock after selling 274,944 shares during the quarter. Vanguard Group Inc. owned 12.35% of Globe Life worth $1,430,349,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in GL. Norges Bank acquired a new stake in shares of Globe Life in the second quarter valued at about $157,722,000. AQR Capital Management LLC increased its holdings in Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after buying an additional 696,548 shares in the last quarter. Invesco Ltd. lifted its position in shares of Globe Life by 3.9% during the 2nd quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock valued at $487,396,000 after acquiring an additional 147,644 shares during the period. Candriam S.C.A. purchased a new stake in shares of Globe Life during the 2nd quarter worth approximately $17,997,000. Finally, Natixis grew its holdings in shares of Globe Life by 348.3% in the 2nd quarter. Natixis now owns 158,823 shares of the company’s stock worth $19,740,000 after acquiring an additional 123,396 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Stock Up 0.3%

Shares of NYSE GL opened at $144.41 on Friday. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The firm’s 50 day moving average price is $141.43 and its 200 day moving average price is $138.59. The firm has a market cap of $11.50 billion, a P/E ratio of 10.26 and a beta of 0.47. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm posted $3.14 earnings per share. The company’s revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on GL shares. Evercore set a $157.00 price objective on Globe Life in a report on Wednesday. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Keefe, Bruyette & Woods raised their price objective on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Finally, Truist Financial raised their price target on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Eight analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $171.22.

Insiders Place Their Bets

In related news, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the sale, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Clay Majors sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the transaction, the executive vice president directly owned 47,066 shares of the company’s stock, valued at $6,913,524.74. This trade represents a 38.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 63,629 shares of company stock valued at $9,223,785 in the last quarter. Corporate insiders own 1.51% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.